UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of ~~August~~November 2025

~~2024~~ Commission File Number: 001-40851

Procaps Group, S.A.

(Translation of registrant’s name in English)

9 rue de Bitbourg, L-1273

Luxembourg

Grand Duchy of Luxembourg

R.C.S. Luxembourg: B253360

Tel: +356 7995-6138

(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

~~Departure~~On November 19, 2025, Procaps Group, S.A. (the “Company”) announced that an extraordinary general meeting of Drshareholders (the “Extraordinary Meeting”) and an annual general meeting of shareholders (the “Annual General Meeting” and together with the Extraordinary Meeting, the “Meetings”) are to be held on Friday, December 5, 2025, at 6:00 p.m. ~~Camilo~~(Luxembourg ~~Camacho~~time).

OnThe ~~July~~record ~~25,~~date ~~2025,~~for the ~~Board~~determination of ~~Directors~~shareholders ~~(the~~entitled ~~“Board”)~~to ofvote ~~Procaps~~at ~~Group,~~the ~~S.A.,~~Meetings ais ~~public~~November ~~limited~~12, ~~liability~~2025. ~~company~~The ~~(société~~Convening ~~anonyme) governed~~Notice byto the ~~laws~~Meetings ofand the ~~Grand~~Proxy ~~Duchy~~Cards offor ~~Luxembourg~~use in ~~(the~~connection ~~“Company”~~with orthe ~~“Procaps”),~~Meetings ~~notified~~are ~~Dr. Camilo~~attached ~~Camacho~~hereto ~~that~~as heExhibit ~~was~~99.1, ~~relieved~~99.2, ofand ~~his~~99.3, ~~duties~~respectively, asand ~~Interim~~will ~~Co-Chief~~be ~~Executive~~mailed ~~Officer~~to of the Company~~, effective immediately~~’s shareholders.

~~Appointment~~The information contained in Exhibit 99.1, Exhibit 99.2, and Exhibit 99.3 are being furnished and shall not be deemed “filed” for the purposes of ~~Chief~~Section 18 ~~Commercial~~of ~~Officer~~the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall they be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise set forth herein or as shall be expressly set forth by specific reference in such a filing.

OnItem 9.01. ~~July~~Financial ~~25,~~Statements ~~2025,~~and ~~the Board of the Company appointed Mr~~Exhibits. ~~Luis Palacios as Chief Commercial Officer of the Company~~

(d) Exhibits

Exhibit Number		Description

99.1		Convening Notice for the Annual and Extraordinary General Meeting of Shareholders of Procaps Group, S.A.
99.2		Form of Proxy Card for the Annual General Meeting of Shareholders of Procaps Group, S.A.
99.3		Form of Proxy Card for the Extraordinary General Meeting of Shareholders of Procaps Group, S.A.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

PROCAPS GROUP, S.A. By: /s/ Melissa Angelini Name: Melissa Angelini Title: Interim ~~Co-~~Chief Executive Officer

Dated: ~~August~~November 119, 2025

Filing Compare · Sofgen Pharma S.A.